Hard Sell

Descriere YEO:

Hard Sell - Disponibil la anticexlibris.ro

Pe YEO găsești Hard Sell de la , în categoria Științe & Cunoaștere > Afaceri & Economie.

Indiferent de nevoile tale, Hard Sell din categoria Științe & Cunoaștere > Afaceri & Economie îți poate aduce un echilibru perfect între calitate și preț, cu avantaje practice și moderne.

Preț: 39.99 Lei

Caracteristicile produsului Hard Sell

• Brand:
• Categoria: Științe & Cunoaștere > Afaceri & Economie
• Magazin: anticexlibris.ro
• Ultima actualizare: 28-10-2025 01:22:05

Comandă Hard Sell Online, Simplu și Rapid

Prin intermediul platformei YEO, poți comanda Hard Sell de la anticexlibris.ro rapid și în siguranță. Bucură-te de o experiență de cumpărături online optimizată și descoperă cele mai bune oferte actualizate constant.

Descriere magazin:
The inside story of a band of entrepreneurial upstarts who made millions selling painkillers—until their scheme unraveled, putting them at the center of a landmark criminal trial. “A fast-paced and maddening account.... Until I read The Hard Sell, about the outrageous behavior of an obscure drug company, I hadn’t appreciated the full extent of the filth or the dark stain the opioid sector has left on the entire industry.... What’s most surprising and powerful about The Hard Sell is not one company’s criminality—we’ve grown inured to corporations behaving badly—as much as how institutionalized these practices were across the modern drug industry.” —New York Times Book Review John Kapoor had already amassed a small fortune in pharmaceuticals when he founded Insys Therapeutics. It was the early 2000s, a boom time for painkillers, and he developed a novel formulation of fentanyl, the most potent opioid on the market. Kapoor, a brilliant immigrant scientist with relentless business instincts, was eager to make the most of his innovation. He gathered around him an ambitious group of young lieutenants. His head of sales—an unstable and unmanageable leader, but a genius of persuasion—built a team willing to pull every lever to close a sale, going so far as to recruit an exotic dancer ready to scrape her way up. They zeroed in on the eccentric and suspect doctors receptive to their methods. Employees at headquarters did their part by deceiving insurance companies. The drug was a niche product, approved only for cancer patients in dire condition, but the company’s leadership pushed it more widely, and together they turned Insys into a Wall Street sensation. But several insiders reached their breaking point and blew the whistle. They sparked a sprawling investigation that would le...